Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial.

Carinna HockhamSradha KotwalArlen WilcoxAbhinav BassiJames McGreeCarol PollockLouise M BurrellNikita BathlaMallikarjuna KunigariVinay RathoreMichael JohnEnmoore LinChristine JenkinsAngus RitchieAndrew McLachlanThomas SnellingMark JonesVivekanand JhaMeg Jardinenull null

Published in: Trials (2021)

ClinicalTrials.gov, NCT04394117 . Registered on 19 May 2020. Clinical Trial Registry of India: CTRI/2020/07/026831).

Keyphrases

angiotensin converting enzyme
clinical trial
coronavirus disease
sars cov
angiotensin ii
randomized controlled trial
phase ii
open label
double blind
phase iii
respiratory syndrome coronavirus